miRNAs in chronic myeloid leukemia: small molecules, essential function

Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment

(2015) Oshrat Hershkovitz-Rokah et al.   CANCER LETTERS

MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein

(2015) Oshrat Hershkovitz-Rokah et al.   CANCER LETTERS

Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway

(2015) Wei-Zhang Wang et al.   LEUKEMIA RESEARCH

Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A

(2015) Burçin Tezcanlı Kaymaz et al.   TUMOR BIOLOGY

MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia

(2015) Zhu Xishan et al.   Scientific Reports

MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors

(2014) L.-S. Wang et al.   BLOOD

Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients

(2014) Dolly Joshi et al.   GENE

Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity

(2013) L. Wang et al.   BLOOD

miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein

(2013) Yajuan Li et al.   EXPERIMENTAL CELL RESEARCH

Epigenetic inactivation of the MIR129-2 in hematological malignancies

(2013) Kwan-Yeung Wong et al.   Journal of Hematology & Oncology

Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia

(2013) Yue Liu et al.   LEUKEMIA RESEARCH

Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate

(2013) Yajuan Li et al.   PLoS One

microRNAs and RNA-binding proteins

(2013) Silvia Anna Ciafrè et al.   RNA Biology

Targeted Therapies in Hematology and Their Impact on Patient Care: Chronic and Acute Myeloid Leukemia

(2013) Elias Jabbour et al.   SEMINARS IN HEMATOLOGY

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia

(2013) Neda Mosakhani et al.   Molecular Cytogenetics

DNA methylation and microRNA dysregulation in cancer

(2012) Hiromu Suzuki et al.   Molecular Oncology

miR-181a Post-Transcriptionally Downregulates Oncogenic RalA and Contributes to Growth Inhibition and Apoptosis in Chronic Myelogenous Leukemia (CML)

(2012) Jia Fei et al.   PLoS One

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies

(2011) Chor Sang Chim et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

(2011) Chor Sang Chim et al.   Journal of Translational Medicine

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

(2011) Kwan Yeung Wong et al.   PLoS One

MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML

(2011) Sukanya Suresh et al.   Journal of Cell Communication and Signaling

Epigenetic inactivation of the miR-34a in hematological malignancies

(2010) C.S. Chim et al.   CARCINOGENESIS

Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia

(2010) E. I. Zimmerman et al.   MOLECULAR PHARMACOLOGY

MicroRNAs, macrocontrol: Regulation of miRNA processing

(2010) I. Slezak-Prochazka et al.   RNA

Iron overload in Asia

(2009) C. Hershko   BLOOD

The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data

(2009) V. G. Oehler et al.   BLOOD

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

(2009) D. Bixby et al.   Hematology-American Society of Hematology Education Program

Chronic myelogenous leukemia: ESMO Clinical Recommendations for the diagnosis, treatment and follow-up

(2008) A. Hochhaus et al.   ANNALS OF ONCOLOGY

Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression

(2008) María J. Bueno et al.   CANCER CELL

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH